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Synopsis
Objectives:  Carbapenemases  are  a  major  concern  for  the  treatment  of 
infectious  diseases  produced  by  Gram-negative  bacteria.  Although 
plasmids are responsible for the spread of resistance genes among these 
pathogens, there is limited information on the nature of the mobile genetic 
elements carrying carbapenemases in Pseudomonas aeruginosa. 
Methods:  We  combined  data  from  two  different  next  generation 
sequencing platforms, Ilumina HiSeq2000 and PacBio RSII,  to obtain the 
complete nucleotide sequence of two  blaVIM-1-carrying plasmids (pAMBL1 
and pAMBL2) isolated from P. aeruginosa clinical isolates.
Results:  Plasmid  pAMBL1  has  26,440  bp  and  carries  a  RepA_C  family 
replication protein. pAMBL1 is similar to plasmids pNOR-2000 and pKLC102 
from  P. aeruginosa and pAX22 from  Achromobacter xylosoxidans,  which 
also carry VIM-type carbapenemases. pAMBL2 is a 24,133 bp plasmid with 
a replication protein that belongs to the Rep_3 family. It shows high degree 
of  homology with a fragment of  the  blaVIM-1-bearing plasmid pPC9 from 
Pseudomonas putida. Plasmid pAMBL2 carries three copies of the  blaVIM-1 
cassette in an In70 class 1 integron conferring, unlike pAMBL1, high level 
resistance to carbapenems.
Conclusions:  Here  we  present  two  new  plasmids  coding  for  VIM-1 
carbapenemase from  P.  aeruginosa  and we report  that the presence of 
three  copies  of  blaVIM-1 in  pAMBL2  produces  high-level  resistance  to 
carbapenems.  
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Introduction
P. aeruginosa produces opportunistic infections that are hard to treat due 
to  its  great  ability  to  develop  resistance  to  antibiotics.  Although 
chromosomally-encoded resistance mechanisms are often responsible for 
this  phenotype,1 plasmids  also  play  a  key  role  in  the  acquisition  of 
antibiotic  multi-drug-resistance in  this  species.  Plasmids  from  P. 
aeruginosa often  carry  the  same  antibiotic  resistance  genes  found  on 
mobile genetic  elements from  Enterobacteriaceae.  Among these genes, 
those  encoding  metallo-β-lactamases  such  as  VIM-type  enzymes  are 
specially  important  since  they  can  hydrolyse  all  β-lactams  including 
carbapenems,  one  of  the  last  resorts of  therapeutic  treatment  for 
infections  caused  by  Enterobacteriaceae.  Despite  their  clinical 
significance, there is little information available on the nature of plasmids 
carrying  carbapenemases  in  P.  aeruginosa,2 or  on  the  routes  of 
dissemination  of  these  resistance  genes  between  pseudomonas  and 
enterobacteria.  
pAMBL1 and pAMBL2 are two blaVIM-1-carrying plasmids recovered from P. 
aeruginosa clinical  isolates at  the  Ramon y Cajal  University  Hospital in 
Madrid,  Spain,  in  2006-2007,  during  an  outbreak  of  VIM-producing 
bacteria.3 Here,  we  combined  Ilumina  HiSeq2000  and  PacBio  RSII 
technologies to determine the complete nucleotide sequence of pAMBL1 
and pAMBL2. This strategy allowed us to detect three copies of  blaVIM-1  β-
lactamase gene inside an integron in pAMBL2, which conferred high-level 
resistance to meropenem in P. aeruginosa PAO1.
Materials and methods
Bacterial strains, culture conditions and antibiotic susceptibility testing. 
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Plasmid pAMBL1 and pAMBL2 were recovered from P. aeruginosa isolates 
in  the  pneumology  ward  in  2006  and  in  the  urology  ward  in  2007, 
respectively, at the Ramon y Cajal University Hospital in Madrid.3 Bacterial 
strains were cultured in LB broth at 37°C (225 rpm) and on Luria Bertani 
agar plates at 37°C (Fisher Scientific, USA). Plasmids were electroporated 
into  P.  aeruginosa  PAO1.4 Transformants  were  selected  on  plates  with 
carbenicillin 256 mg/L and ceftazidime 50 mg/L. We performed conjugation 
experiments as previously described3 using a GFP-tagged  P.  aeruginosa 
PAO1 (chloramphenicol and gentamicin resistant)4 as a recipient strain and 
PAO1/pAMBL1  and  PAO1/pAMBL2  as  donors.  Susceptibility  testing  was 
performed  by  broth  microdilution  method  according  to  the  CLSI 
guidelines.5 The  MICs  were  determined  as  the  mean  of  three  or  four 
independent experiments (Table 1). 
DNA analysis, sequencing and bioinformatics
DNA samples were obtained using Qiagen Dneasy Blood and Tissue Kit 
(Qiagen, USA) and quantified using QuantiFluor dsDNA system (Promega, 
USA). Library preparation and sequencing was performed at the Wellcome 
Trust Centre for Human Genetics, University of Oxford (using HiSeq2000 
and 100-bp-paired end reads, average median depth of coverage 70x) and 
at The Genome Analysis Centre in Norwich (PacBio RS platform using P5-
C3 chemistry,  average median depth of coverage 50x). To assemble de 
novo the paired end reads obtained with Illumina technology we used A5 
pipeline  (developed  for  microbial  genomes).6 We  used  Geneious  7.1.7 
(Biomatters,  USA)  to  analyse  the  reads  from  PacBio.  To  annotate  the 
plasmids  we  used  RAST  server,7 and  confirmed  the  annotation  doing 
BLASTP similarity searches of each predicted protein. Plasmid sequences 
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were confirmed by restriction profile  with  endonucleases  HindIII,  EcoRI, 
XhoI,  KpnI,  BamHI (New England BioLabs, USA),  by PCR mapping and by 
Sanger  sequencing  the  complete  integron  in  pAMBL2 and  all  the 
ambiguous residues (Table S1). RNA extraction and RNA-Seq analysis were 
performed as described in San Millan et al. 2015.8
Results and discussion
Sequencing of plasmids pAMBL1 and pAMBL2
We transformed P. aeruginosa PAO1 with plasmid pAMBL1 and pAMBL2.4 To 
determine  the  complete  nucleotide  sequence  of  the  plasmids,  we 
extracted the genomic  DNA from PAO1/pAMBL1 and PAO1/pAMBL2 and 
sequenced  the  samples  using  Ilumina  HiSeq2000.  After  filtering  PAO1 
chromosomal  DNA and assembling the remaining reads,  we obtained a 
single contig for pAMBL1 that was manually closed to a circle. However, 
for pAMBL2 we obtained two non-overlapping contigs, which could not be 
linked by PCR. A limitation of assembling bacterial genomes using Illumina 
technology is that reads are short (ca. 100bp), and this affects the power 
to  assemble  DNA  regions  containing  long  repeats  and  duplications.9 
Therefore, we sequenced both DNA samples using PacBio RSII technology, 
which has a higher error rate than the Ilumina technology but produces 
longer  reads  (average=  6kb).  PacBio  data  helped  solving  the  overall 
structure of the plasmids. By combining the results obtained with the two 
platforms, we were able to determine the exact nucleotide sequence of 
plasmids pAMBL1 and pAMBL2. 
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This work enlarges the list of plasmids from P. aeruginosa, which despite 
the  relevance  of  this  species  as  opportunistic  pathogen,  are 
underrepresented  in  the  plasmid  genome  database 
(http://www.ncbi.nlm.nih.gov/genome/?term=pseudomonas+aeruginosa).
Analysis of pAMBL1 
pAMBL1  conferred  resistance  to  gentamicin,  carbenicillin,  ceftazidime, 
meropenem and mercury in P. aeruginosa PAO1 (Table 1) and was not able 
to conjugate under our experimental conditions. It was 26,440 bp in size, 
had an average GC content of 63.5% and contained 29 ORFs (Figure 1a). 
This plasmid carried a replication protein belonging to the RepA_C family 
and  presented  a  backbone  structure  containing  the  replication, 
partitioning  and  mobilization  genes  which  was  very  similar  to  the 
equivalent region in three plasmids: (i) the blaVIM-2 carrying plasmid pNOR-
2000  from  P.  aeruginosa,10 (ii)  plasmid  pAX22  from  Achromobacter 
xylosoxidans,  which  also  carries blaVIM-1,11 and  (iii)  TnCP23,  a  plasmid 
inserted  into  the  chromosomally  integrated  element  pKLC102  of  P. 
aeruginosa strain  C12 (Figure  1a).  pAMBL1  also  carried  a  Tn5563a 
element,13 inserted in the traG gene, carrying putative mercury resistance 
genes (Table  1),  and a defective Tn402 transposon carrying  aadB and 
blaVIM-1 cassettes in a class 1 integron. Additionally, pAMBL1 also harboured 
a serine protease gene,  degP, similar to the one in pNOR-2000,10 and a 
putative  efflux  pump  and  its  transcriptional  regulator  showing  99% 
nucleotide identity with those found in Enterobacter spp. plasmid pENT01 
(Accession NC_021492.1). 
Analysis of pAMBL2 
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Plasmid  pAMBL2  conferred  resistance  to  streptomycin,  kanamycin, 
carbenicillin,  ceftazidime and meropenem in PAO1 (Table 1)  and it  was 
unable to conjugate. This plasmid presented a length of 24,133 bp, with an 
average  GC  content  of  60.4%,  and  it  coded  for  35  predicted  ORFs 
including a Rep_3 family replication protein. pAMBL2 was very similar to a 
segment of pPC9, an 80 kb multi-drug resistance plasmid from a clinical 
isolate of  Pseudomonas putida14.  pAMBL2 backbone was also similar to 
pCT14 from a  Pseudomonas  spp. isolated from activated sludge (Figure 
1b).15 Apart  from  the  replication  and  partitioning  genes,  pAMBL2  also 
carried an ISPa17 element coding for a toxin-antitoxin system.16 ISPa17 
has been suggested to mobilize defective Tn402-like transposons carrying 
class 1 integrons.11 We found that pAMBL2 contained three copies of the 
blaVIM-1  carbapenemase  gene  cassette  inside  the  In70  class  1  integron, 
which also carried aacA4, aadA1, qacEΔ1 and sul1 cassettes.
Interestingly, pAMBL2 conferred high-level resistance to meropenem in P. 
aeruginosa PAO1 (MIC, average= 192 mg/L, SD=74 mg/L, n= 4). Actually, 
meropenem resistance was higher in PAO1/pAMBL2 than in PAO1/pAMBL1 
(MIC, average= 80 mg/L,  SD=32, n=4), which carries only one copy of 
blaVIM-1 (Paired t-test, P= 0.035, t3= -3.66). Given that these two plasmids 
carry  blaVIM-1 in  class  1  integrons  with  identical  promoters  for  the 
expression of the cassettes (PcW),17 and that both plasmids have similar 
copy numbers in PAO1,4 this result suggested that the triplication of blaVIM-1 
is responsible for the increase in meropenem resistance.  To confirm this 
hypothesis we used RNA-Seq (data from San Millan et al., in preparation) 
to  measure  the  transcription  of  blaVIM-1.  This  analysis  revealed  a  34% 
increase in the transcription levels of blaVIM-1 in PAO1/pAMBL2 compared to 
PAO1/pAMBL1. In addition, we performed a nitrocefin test18 (a colorimetric 
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assay  that  quantifies  β-lactamase  activity)  with  PAO1/pAMBL1  and 
PAO1/pAMBL2,  and  we  observed  a  1.54-fold  increase  in  β-lactamase 
activity  in  PAO1/pAMBL2  compared  to  PAO1/pAMBL1  (data  not  shown). 
These experiments confirmed that the amplification of blaVIM-1 in pAMBL2 is 
responsible  for  the  high-level  meropenem  resistance  phenotype  in 
PAO1/pAMBL2.
Our  results  suggest  that  metallo-β-lactamase  amplification  could  drive 
high-level  carbapenem resistance in  nature.  This  type  of  amplifications 
could  be  responsible  for  the  carbapenem  heteroresistance  previously 
described in clonally-related  Enterobacteriaceae clinical isolates carrying 
the blaVIM-1 gene.19
Conclusion
Duplication of cassettes in integrons has rarely been described before,20 
but this could be partially due to limitations of the sequencing technology. 
Because  of  the  semiconservative  nature  of  cassette  recombination, 
integron integrases can duplicate cassettes within the array.21, 22 Therefore, 
cassette  duplications  may  be  more  frequent  in  nature  than  previously 
expected.  The  amplification  of  an  antibiotic  resistance  cassette  can 
potentially increase the antibiotic resistance level, as we have observed in 
this  work.  In  addition,  duplications  pave  the  way  for  subsequent 
evolutionary  steps  such  as  the  neo-functionalization  or  sub-
functionalization  of  the  copies,  and  this  could  play  a  key  role  in  the 
evolution of  antibiotic resistance.23 The improvement in the sequencing 
technologies and the combination of several techniques will enhance the 
identification of duplications, increasing the quality and completeness of 
assembled  genomes,9 and  enhancing  our  understanding  of  the  role  of 
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
integrons  in  the  evolution  of  antibiotic  resistance.  Finally,  pAMBL1 and 
pAMBL2 enlarge the list  of  plasmids  with  RepA_C and Rep3 replication 
proteins  described  in  Pseudomonas  species, which  seem  to  have 
remarkable interest for epidemiological purposes. 
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Figures 
Figure 1. Plasmids pAMBL1 and pAMBL2
Schematic representation of plasmids (a) pAMBL1 and (b) pAMBL2. The 
reading  frames  for  genes  are  shown  as  arrows,  with  the  direction  of 
transcription indicated by the arrowhead. Green arrows represent genes 
involved in plasmid housekeeping functions such as replication, partition, 
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stability  or conjugation.  Red arrows indicate genes responsible for DNA 
rearrangements  (such  as  transposases  or  integrases).  Blue  arrows 
represent accessory genes coding for selectable traits (including antibiotic 
resistance).  Genes  of  unknown  function  are  shown  in  grey.  The  inner 
circles represent regions of homology with previously described plasmids 
(>80%  of  nucleotide  identity).  In  panel  a,  the  outer  dark  grey  circle 
represents  plasmid  TnCP23  from  P.  aeruginosa,  the  middle  circle 
corresponds to plasmid pAX22 from  A. xylosoxidans and the inner light 
grey circle represents plasmid pNOR-2000 from P. aeruginosa. In panel b, 
the outer dark grey circle represents plasmid pPC9 from  P. putida.  The 
middle circle corresponds to plasmid pAX22 from A. xylosoxidans and the 
inner light grey circle represents plasmid pCT14 from Pseudomonas  spp. 
This figure appears in colour in the online version of JAC and in black and 
white in the printed version of JAC.
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Tables
Table 1. Antibiotic susceptibility profile of the strains used in this study
Strain
Minimal inhibitory concentration (mg/L)
STR GEN KAN CAR CAZ MER Hg
P. aeruginosa 
PAO1
8 0.2 171 53 1 0.5 0.7
PAO1/ pAMBL1 16 85 256 8,192 683 80 5
PAO1/ pAMBL2 2,048 13 512
16,38
4
1,36
5
192 0.5
The  minimal  inhibitory  concentrations  are  the  mean  of  three  or  four 
independent  experiments.  STR,  streptomycin;  GEN,  gentamicin;  KAN, 
kanamycin;  CAR,  carbenicillin;  CAZ,  ceftazidime;  MER,  meropenem;  Hg, 
mercury.  The  data  of  this  table  has  been  partially  retrieved  from  the 
supplementary information of San Millan et al. 2014.4 
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